Spironolactone During Menopause: How It Can Help with Your Thinning Hair

You want to look and feel your best during menopause. You've earned it.

But suddenly you're battling acne and thinning hair. Or maybe even increased facial hair that was definitely not invited.

We see you. You're busy crushing midlife, so let's talk about why these symptoms develop and why spironolactone is sometimes prescribed to treat them.

Why Skin and Hair Changes Happen During Perimenopause and Menopause

During the transition to menopause, estrogen levels fluctuate and eventually decline. As this happens, androgen activity can become more noticeable, increasing oil production and potentially resulting in the formation of acne on the chin and along the jawline. Increased androgen levels are also responsible for facial hair growth and thinning of scalp hair.

Not every woman in midlife experiences these symptoms, but when they appear along with other symptoms of menopause, it’s a clue that hormones might be a part of the cause.

I find that after about 3 months of hormone therapy, patients tend to notice skin changes characterized by softer skin texture, smoother skin, and a reduction in acne prone areas.  

Are Hormones Always the Cause?

No, declining estrogen is not the only cause of skin and hair concerns during midlife.

Shifting hormones are one reason for changes in acne patterns and hair growth, but these symptoms can also be caused by genetics and aging. Genetics can influence how hair follicles and oil glands respond to hormones and aging itself can affect skin quality and hair density. Certain medical conditions and medications can also impact skin quality and hair growth.

Two women may experience similar symptoms for very different reasons. Because the underlying cause is not always the same, treatment decisions should be individualized.

Where Spironolactone Fits Among Treatment Options

Several treatment approaches are available, and the best option depends on which symptoms are present and what is causing them.

Acne may be managed with topical treatments, oral medications, or hormone replacement therapy. Hair thinning may be treated with topical or oral minoxidil in appropriate candidates. Hormone therapy may improve multiple menopause-related symptoms in some women.

Anti-androgen medications are sometimes used when androgen activity appears to be contributing to symptoms. One anti-androgen commonly prescribed for hormone-related skin and hair concerns is spironolactone

What Is Spironolactone and How Does It Work?

Spironolactone is a diuretic and was originally developed to treat high blood pressure. It is useful for some symptoms in menopause because it also blocks androgen activity at the skin and hair follicle level. The result is reduced oil production and a decrease in some androgen-related skin and hair changes.

Dermatologists commonly prescribe spironolactone for hormonal acne, unwanted facial hair growth, and certain forms of female-pattern hair loss. It is taken as a daily oral prescription under clinician supervision.

Who May Benefit from taking Spironolactone?

Spironolactone is used most often for symptoms related to increased androgen levels. Often this is hormonal acne that persists after trying topical treatments, especially concentrated around their lower face and jawline. Because hair follicles and skin are both affected by androgen activity, unwanted facial hair and hair loss commonly appear with hormonal acne.

However, the presence of these symptoms alone does not determine whether the medication is appropriate. The decision to use spironolactone depends on symptoms, health history, and patient goals.

How Long Does Spironolactone Take to Work?

Acne treated with spironolactone may begin improving after several weeks, with noticeable improvement often requiring 8 to 12 weeks. Hair-related results generally take longer because hair growth cycles are slow. Some women may notice that shedding of their hair slows before the hair density starts to improve. Treatment may need several months before any effects are visible.

With both, consistent use and follow-up are important.

Common Side Effects and Safety Considerations

Common side effects may include increased urination, dizziness, fatigue, headache, or breast tenderness. Increased urination is often most noticeable when treatment is first started and may improve as the dose is adjusted.

Spironolactone is safe for most women. However, there are some women who should avoid it.

Spironolactone is known as a “potassium-sparing diuretic” which means it increases fluid leaving the body, while preventing any potassium from being lost. While this is generally beneficial, it carries a small risk for causing too much potassium to build up in the blood. This risk is increased in women with kidney disease and women who take certain medications such as lisinopril and  losartan for blood pressure. Women who are pregnant or breast feeding should also not take spironolactone.

It is important to make sure a clinician reviews all medications and medical conditions before beginning spironolactone.

How Alloy Approaches Spironolactone Treatment

Not every woman experiencing hair loss or acne during menopause needs spironolactone. This is one reason determining the underlying cause of symptoms is often more important than matching a treatment to a symptom alone.

Alloy’s menopause-informed physicians understand that treatment decisions for skin and hair changes during midlife are not always based on symptoms alone and should be determined after evaluating medical history, current medications, and treatment goals.

At Alloy, we believe that we’ve earned the right to look and feel fantastic during menopause. And we believe that finding the right treatment means finding someone who understands the full picture. Our bodies have different clinical needs than earlier in life and should be treated by experts in midlife care.

Because we deserve to feel good.

Frequently Asked Questions

Why do some women experience acne, thinning hair, and unwanted facial hair during perimenopause and menopause?

During the menopause transition, estrogen levels fluctuate and eventually decline. This drop allows androgen activity to become more noticeable. The increase in androgen activity triggers higher oil production, which often leads to acne on the chin and jawline. These shifting hormones are also directly responsible for causing scalp hair to thin and unwanted facial hair to grow. However, these changes are not solely caused by declining estrogen; aging, genetics, certain medical conditions, and specific medications can also impact skin quality and hair density.

What is spironolactone and how does it help treat menopause-related skin and hair changes?

Spironolactone is a daily oral prescription medication under clinician supervision that was originally developed as a diuretic to treat high blood pressure. In menopause, it is useful because it acts as an anti-androgen, meaning it blocks androgen activity at the skin and hair follicle level. By reducing oil production and blocking these hormones, it helps decrease hormonal acne—especially around the lower face and jawline—while also treating unwanted facial hair growth and certain forms of female-pattern hair loss.

What are the side effects of spironolactone and who should avoid taking it?

Common side effects of spironolactone include increased urination, dizziness, fatigue, headache, and breast tenderness, with frequent urination being most noticeable when first starting the medication. Because spironolactone is a potassium-sparing diuretic, it prevents potassium from leaving the body, creating a small risk of high potassium buildup in the blood. Due to this risk, women with kidney disease and those taking certain blood pressure medications like lisinopril or losartan should avoid it. It should also be avoided by women who are pregnant or breastfeeding.

References

1. Kaufman MR, Ackerman AL, Amin KA, et al. The AUA/SUFU/AUGS guideline on genitourinary syndrome of menopause. J Urol. 2025;214(3):703-716. doi:10.1097/JU.0000000000004702

2. The Menopause Society. Hormone therapy position statement advisory panel. The 2022 hormone therapy position statement of The Menopause Society. Menopause. 2022;29(7):767-794. doi:10.1097/GME.0000000000002028

3. American Academy of Dermatology Association. Acne: Diagnosis and treatment. Accessed June 5, 2026. https://www.aad.org/public/diseases/acne/derm-treat/treat

4. Layton AM. Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris. Dermatol Clin. 2016;34(2):147-157. doi:10.1016/j.det.2015.11.008Burns LJ, Mostaghimi A, Eady EA, et al. Effectiveness of spironolactone for women with acne vulgaris (SAFA): a randomized controlled trial. BMJ. 2023;381:e074349. doi:10.1136/bmj-2022-074349

5. Famenini S, Goh C. Evidence for supplemental treatments in androgenetic alopecia. J Drugs Dermatol. 2014;13(7):809-812.

6. Pfizer Laboratories Div Pfizer Inc. Aldactone (spironolactone) prescribing information. Revised January 2025. Accessed June 5, 2026. https://www.accessdata.fda.gov